Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis
about
PARticipation in inflammationBeta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transductionThe emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disordersInduction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2Can PRP effectively treat injured tendons?Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsCrystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1PAR-2 agonists induce contraction of murine small intestine through neurokinin receptorsProtease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivoSensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory painContribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitisLoss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladdersProfiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cellsModulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cellsA major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndromeActivation of protease activated receptor 2 by exogenous agonist exacerbates early radiation injury in rat intestineImportance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitisProtease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium.Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.Functional protease-activated receptors in the dorsal motor nucleus of the vagus.Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.HGF mediates the anti-inflammatory effects of PRP on injured tendons.Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis.2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice.Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2)Immune networks in animal models of inflammatory bowel disease.Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.Modulation of visceral pain and inflammation by protease-activated receptors.Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder.Protease-activated receptor-2 augments experimental crescentic glomerulonephritisClinical relevance of proteinase activated receptors (pars) in the gutProtease-activated receptors and inflammatory hyperalgesia.Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?
P2860
Q24554366-2A912E34-6D7F-420F-8EB3-DB5CA4DACA44Q24653656-330152D6-DBD8-4900-9AE3-CC71C6E7E26BQ24679499-9F7A19CA-6962-4671-B70A-DEE307CC9D7CQ24685396-6B33A6FD-27CB-4AFD-8E9C-215B78D53B09Q26863265-B6C37D22-7FAC-4EAE-8867-02E4A2C84FB9Q27027602-0CD4AEBA-7EEA-4FD8-880C-6E7EE3D36183Q27660263-E27C85D4-D7EA-410F-9928-BAAD3C4A5AEEQ28178533-83D70FFB-BAF4-4D94-BD10-AF67516AA887Q28511351-8451A98E-5653-4407-895A-226C853564A6Q28757606-CF4D66C7-7A36-47B9-B84E-796EA752AE99Q30495905-06D74BAA-29C0-41C7-A016-B25EA6A9B07FQ33696394-95B053E8-80EB-424D-B77E-F2185ACE0786Q33745121-76E1AA52-079D-4044-BD79-8FD75CFC3FAFQ33756072-C6253E13-2264-4C69-BF56-B67E37D34FCEQ33852062-187A761D-048C-49DC-AF10-E48C9ADED12AQ33872709-03D8BEB9-5133-48BB-9004-7B53934176D7Q33984148-F2366B69-60E7-47F5-9BD2-7C37C52FC938Q34073928-17112510-931F-49B3-91CD-20C355E96A40Q34222208-D13DDBE7-3442-4235-BF4E-E898723E2096Q34233126-191B9596-FF60-4D66-A593-BD4A05DD7CBBQ34389791-ED786287-C2F5-4C1C-8EB1-5A4A6BB68760Q34501717-51A39E91-27B1-4A9C-A9D1-C1F86E5C37EAQ34573050-7166BBDC-BBFC-464D-BB12-2F383EBE38E2Q34642699-8922CE0F-315F-4933-A375-1B46B5591356Q34700750-EB436BAF-AB5A-4410-AA16-22C13A12BBC2Q34807000-08F132BC-C12B-4B2F-9836-C2AF7D77D89DQ34974341-054BB580-693F-4665-8F8B-D99F72CB3EBBQ35048527-7439184C-A9BE-4BC7-A2DD-453D8C5044EAQ35100835-F7FC9E75-F68E-44A3-A1CB-73BD6EE35424Q35107372-C225269D-3AEF-4CCC-9EC8-984D83BBA6E5Q35193871-0C20C8B2-C668-447E-AF8F-3BEC02058B1AQ35221859-BEB9B8B0-D7E2-4642-BEE8-DE81547A27B9Q35722704-569EDBB1-2E5B-4EB7-9FEB-9525B30B8A14Q35745630-54708B03-1EFF-4686-B1E4-46BDDFC3C30CQ35791283-3F9D9B96-1BBC-4DA9-81A1-64BFF848AA15Q35963188-B9E64998-537E-4151-97D4-10102D0A8152Q36124432-BCF600CB-F131-4787-9E19-92C8B78143ADQ36165918-06F04F63-9080-41D6-AD8E-612FF3853628Q36228251-30DD6B97-6FEE-4794-B284-D63586B099CFQ36268344-3391DABD-4A11-4656-8A33-496F0230B3CE
P2860
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Proteinase-activated receptor ...... es in a mouse model of colitis
@ast
Proteinase-activated receptor ...... es in a mouse model of colitis
@en
Proteinase-activated receptor ...... es in a mouse model of colitis
@nl
type
label
Proteinase-activated receptor ...... es in a mouse model of colitis
@ast
Proteinase-activated receptor ...... es in a mouse model of colitis
@en
Proteinase-activated receptor ...... es in a mouse model of colitis
@nl
prefLabel
Proteinase-activated receptor ...... es in a mouse model of colitis
@ast
Proteinase-activated receptor ...... es in a mouse model of colitis
@en
Proteinase-activated receptor ...... es in a mouse model of colitis
@nl
P2093
P2860
P356
P1476
Proteinase-activated receptor ...... es in a mouse model of colitis
@en
P2093
A Mencarelli
B Palazzetti
E Distrutti
J L Wallace
M D Hollenberg
S Fiorucci
P2860
P304
P356
10.1073/PNAS.241377298
P407
P577
2001-11-20T00:00:00Z